FDA Guidance Recommends Evaluating Wider Range of Doses in Oncology Trials
March 31, 2023
Oncology drug trials should consider a wide range of dosages and how they impact a wide variety of participants, rather than immediately titrating patients up to the maximum tolerated dose (MTD), the FDA said in a new draft guidance.